NCT06082570 2023-10-13
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
Clinical Trials
12 trialsNCT05976906 2023-08-04
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
Zhejiang University
Phase 1 Unknown
NCT05972460 2023-08-02
IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Unknown
NCT05942378 2023-07-12
A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors
Fudan University
Phase 1 Unknown
NCT05502393 2022-08-16
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Unknown
NCT05194709 2022-02-02
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors
Wuxi People's Hospital
Phase EARLY_PHASE1 Unknown
NCT03415659 2020-02-17
Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors
Hubei Biological Medicine Industrial Technology Institute Co., Ltd.
Phase 1 Unknown
NCT03787953 2019-05-16
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
Chinese PLA General Hospital
Unknown
NCT01867073 2013-06-03
A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours
National University Hospital, Singapore
Unknown
NCT01155505 2011-09-13
Lenalidomide and Paclitaxel in Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown
NCT01159418 2011-09-13
LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown
NCT01220284 2010-10-13
Satraplatin and Vinorelbine in Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown